Clinical trial
PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to…
NCT00491998 · Vernalis (R&D) Ltd, Industry · Completed
Key facts
| NCT number | NCT00491998 |
|---|---|
| Title | PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets |
| Official title | Randomised, Double-blind, Double-dummy, Two-period, Cross-over Study to Determine the PK, PD and Safety of Multiple Doses of V1512 Effervescent Tablets in Parkinson's Disease Patients Compared to Sinemet® Oral Tablets |
| Lead sponsor | Vernalis (R&D) Ltd, Industry |
| Collaborators | Cita NeuroPharmaceuticals Industry Syneos Health |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | V1512, V1512 and Entacapone |
| Enrollment | 27 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jun 27, 2007 |
| Last update posted | Jul 25, 2011 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: